Oberoi Realty hit a fresh high of Rs 438, up 8% on BSE in an other wise weak market in intra-day trade, after the company announced that GlaxoSmithKline Pharmaceuticals Limited ('GSK') has selected the real estate company as the successful bidder for its Thane property.
“GlaxoSmithKline Pharmaceuticals Limited ('GSK') has selected Oberoi Realty Limited as the successful bidder for the land admeasuring approximately 60 acres located at Thane, Maharashtra,” Oberoi Realty said in a BSE filing.
The Company's bid for purchase of the said land was for a consideration of Rs 555 crore, it added.
The proposed
“GlaxoSmithKline Pharmaceuticals Limited ('GSK') has selected Oberoi Realty Limited as the successful bidder for the land admeasuring approximately 60 acres located at Thane, Maharashtra,” Oberoi Realty said in a BSE filing.
The Company's bid for purchase of the said land was for a consideration of Rs 555 crore, it added.
The proposed